These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7737240)

  • 1. Stable isotope methodology for studying the performance of metoprolol Oros tablets in comparison to conventional and slow release formulations.
    Richard J; Cardot JM; Godbillon J
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):375-80. PubMed ID: 7737240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
    Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
    Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.
    Plosker GL; Clissold SP
    Drugs; 1992 Mar; 43(3):382-414. PubMed ID: 1374320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of site of drug delivery on the systemic availability of metoprolol: comparison of intragastric infusion and 14/190 Oros administration.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Wardle HM; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):219S-224S. PubMed ID: 4005126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing.
    Sandberg A; Abrahamsson B; Svenheden A; Olofsson B; Bergstrand R
    Pharm Res; 1993 Jan; 10(1):28-34. PubMed ID: 8430057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
    Grainger SL; John VA; Shotton PA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conscious and anaesthetised Göttingen mini-pigs as an in-vivo model for buccal absorption - pH-dependent absorption of metoprolol from bioadhesive tablets.
    Meng-Lund E; Jacobsen J; Andersen MB; Jespersen ML; Karlsson JJ; Garmer M; Jørgensen EB; Holm R
    Drug Dev Ind Pharm; 2014 May; 40(5):604-10. PubMed ID: 24724915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of food on the absorption of metoprolol administered as an Oros drug delivery system to man.
    Lecaillon JB; Massias P; Schoeller JP; Abadie F
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):245S-249S. PubMed ID: 4005130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.
    Godbillon J; Gerardin A; Richard J; Leroy D; Moppert J
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):213S-218S. PubMed ID: 4005125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oros controlled-release formulations of metoprolol: an approach to the development of a system for once daily administration.
    Good W; Leeson LJ; Zak SL; Wagner WE; Meeker JB; Arnold JD
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):231S-238S. PubMed ID: 4005128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations.
    Rekhi GS; Eddington ND; Fossler MJ; Schwartz P; Lesko LJ; Augsburger LL
    Pharm Dev Technol; 1997 Feb; 2(1):11-24. PubMed ID: 9552427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter- and intra-subject variability of metoprolol kinetics after intravenous administration.
    Richard J; Cardot JM; Godbillon J
    Eur J Drug Metab Pharmacokinet; 1994; 19(2):157-62. PubMed ID: 8001596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers.
    van den Berg G; van Steveninck F; Gubbens-Stibbe JM; Schoemaker HC; de Boer AG; Cohen AF
    Eur J Clin Pharmacol; 1990; 39(3):315-6. PubMed ID: 2257873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of sustained-release tablets of metoprolol in Chinese.
    Diao Y; Li L
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):232-4. PubMed ID: 8237398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
    Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
    Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug.
    Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS
    Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
    Oosterhuis B; Jonkman J; Zuiderwijk P; Sollie F
    J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.